ID	Gene Name	Species	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
Q9W1H4	DNA ligase 1(DNAlig1)	Drosophila melanogaster			GO:0006266~DNA ligation,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,GO:1903461~Okazaki fragment processing involved in mitotic DNA replication,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0003910~DNA ligase (ATP) activity,GO:0005524~ATP binding,	IPR000977:DNA_ligase_ATP-dep,IPR012308:DNA_ligase_ATP-dep_N,IPR012309:DNA_ligase_ATP-dep_C,IPR012310:DNA_ligase_ATP-dep_cent,IPR012340:NA-bd_OB-fold,IPR016059:DNA_ligase_ATP-dep_CS,IPR036599:DNA_ligase_N_sf,IPR050191:ATP-dep_DNA_ligase,					KW-0131~Cell cycle,KW-0132~Cell division,KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0235~DNA replication,	KW-0539~Nucleus,			KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0436~Ligase,	KW-0597~Phosphoprotein,	ACT_SITE:N6-AMP-lysine intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,
Q9NPF5	DNA methyltransferase 1 associated protein 1(DMAP1)	Homo sapiens			GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006281~DNA repair,GO:0006338~chromatin remodeling,GO:0006355~regulation of DNA-templated transcription,GO:0042307~positive regulation of protein import into nucleus,GO:0042981~regulation of apoptotic process,GO:0045471~response to ethanol,GO:0045892~negative regulation of DNA-templated transcription,GO:0045893~positive regulation of DNA-templated transcription,GO:0051726~regulation of cell cycle,GO:1905168~positive regulation of double-strand break repair via homologous recombination,GO:2000779~regulation of double-strand break repair,	GO:0000786~nucleosome,GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0061629~RNA polymerase II-specific DNA-binding transcription factor binding,	IPR008468:DMAP1,IPR027109:Swc4/Dmap1,IPR032563:DAMP1_SANT-like,	hsa03082:ATP-dependent chromatin remodeling,				KW-0341~Growth regulation,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0175~Coiled coil,		KW-0010~Activator,KW-0156~Chromatin regulator,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:DAMP1 SANT/Myb-like,DOMAIN:DNA methyltransferase 1-associated 1,DOMAIN:SANT,REGION:Disordered,
Q9CYL5	GLI pathogenesis-related 2(Glipr2)	Mus musculus			GO:0010634~positive regulation of epithelial cell migration,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0042803~protein homodimerization activity,	IPR001283:CRISP-related,IPR002413:V5_allergen-like,IPR014044:CAP_dom,IPR018244:Allrgn_V5/Tpx1_CS,IPR034113:SCP_GAPR1-like,IPR035940:CAP_sf,				SM00198:SCP,		KW-0333~Golgi apparatus,KW-0472~Membrane,		KW-0175~Coiled coil,			KW-0449~Lipoprotein,KW-0519~Myristate,	DOMAIN:SCP,LIPID:N-myristoyl glycine,REGION:Interaction with CAV1,
P51688	N-sulfoglucosamine sulfohydrolase(SGSH)	Homo sapiens		Inorganic ion transport and metabolism,	GO:0006027~glycosaminoglycan catabolic process,GO:0008340~determination of adult lifespan,GO:0030200~heparan sulfate proteoglycan catabolic process,GO:0061744~motor behavior,	GO:0005764~lysosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008484~sulfuric ester hydrolase activity,GO:0016250~N-sulfoglucosamine sulfohydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase_N,IPR017850:Alkaline_phosphatase_core_sf,IPR024607:Sulfatase_CS,IPR032506:SGSH_C,IPR050738:Sulfatase,IPR052701:GAG_Ulvan_Degrading_Sulfatases,	hsa00531:Glycosaminoglycan degradation,hsa01100:Metabolic pathways,hsa04142:Lysosome,	252900~Mucopolysaccharidosis type IIIA (Sanfilippo A),				KW-0458~Lysosome,	KW-0225~Disease variant,KW-0510~Mucopolysaccharidosis,	KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	ACT_SITE:Nucleophile,BINDING:via 3-oxoalanine,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:N-sulphoglucosamine sulphohydrolase C-terminal,DOMAIN:Sulfatase N-terminal,REGION:Disordered,
Q6AYK1	RNA binding protein with serine rich domain 1(Rnps1)	Rattus norvegicus			GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008150~biological_process,GO:0008380~RNA splicing,GO:0043065~positive regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0061574~ASAP complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034201:RNPS1_RRM,IPR035979:RBD_domain_sf,	rno03013:Nucleocytoplasmic transport,rno03015:mRNA surveillance pathway,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0866~Nonsense-mediated mRNA decay,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,REGION:Disordered,REGION:Interaction with SAP18 and ACIN1,REGION:Necessary for interaction with PNN and exon-skipping,REGION:Necessary for interaction with SRP54, nuclear localization and exon-skipping,REGION:Necessary for interaction with TRA2B, nuclear localization and exon-skipping,REGION:Necessary for interaction with the cleaved p110 isoform of CDC2L1,REGION:Necessary for interactions with UPF2 and UPF3B and UPF2-dependent NMD,
Q60803	TNF receptor-associated factor 3(Traf3)	Mus musculus	m_cd40Pathway:CD40L Signaling Pathway,m_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.,m_tnfr2Pathway:TNFR2 Signaling Pathway,	Cell division and chromosome partitioning,	GO:0001817~regulation of cytokine production,GO:0002224~toll-like receptor signaling pathway,GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0008063~Toll signaling pathway,GO:0030162~regulation of proteolysis,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032481~positive regulation of type I interferon production,GO:0032648~regulation of interferon-beta production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034142~toll-like receptor 4 signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043122~regulation of canonical NF-kappaB signal transduction,GO:0045087~innate immune response,GO:0050688~regulation of defense response to virus,GO:0070534~protein K63-linked ubiquitination,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0009898~cytoplasmic side of plasma membrane,GO:0010008~endosome membrane,GO:0035631~CD40 receptor complex,GO:0098802~plasma membrane signaling receptor complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031625~ubiquitin protein ligase binding,GO:0031996~thioesterase binding,GO:0035591~signaling adaptor activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001293:Znf_TRAF,IPR001841:Znf_RING,IPR002083:MATH/TRAF_dom,IPR008974:TRAF-like,IPR012227:TNF_rcpt-assoc_TRAF_met,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027128:TRAF3_RING-HC,IPR037304:TRAF3_MATH,IPR049342:TRAF1-6_MATH_dom,IPR049440:TRAF3/5_RING,	mmu04064:NF-kappa B signaling pathway,mmu04620:Toll-like receptor signaling pathway,mmu04621:NOD-like receptor signaling pathway,mmu04622:RIG-I-like receptor signaling pathway,mmu04657:IL-17 signaling pathway,mmu04668:TNF signaling pathway,mmu04936:Alcoholic liver disease,mmu05160:Hepatitis C,mmu05161:Hepatitis B,mmu05162:Measles,mmu05164:Influenza A,mmu05165:Human papillomavirus infection,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05168:Herpes simplex virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05171:Coronavirus disease - COVID-19,mmu05200:Pathways in cancer,mmu05203:Viral carcinogenesis,mmu05222:Small cell lung cancer,mmu05417:Lipid and atherosclerosis,		PIRSF015614:TRAF,	SM00061:MATH,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,KW-0882~Thioester bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:MATH,DOMAIN:RING-type,DOMAIN:TRAF-type,MUTAGEN:C->A: Abolishes inhibition of NFKB2 processing; when associated with A-52.,MUTAGEN:C->A: Abolishes inhibition of NFKB2 processing; when associated with A-55.,MUTAGEN:C->A: Strongly reduces 'Lys-63'-linked ubiquitination; when associated with A-69. Abolishes inhibition of NFKB2 processing; when associated with A-69.,MUTAGEN:F->Y: Loss of interaction with MAVS.,MUTAGEN:H->A: Strongly reduces 'Lys-63'-linked ubiquitination; when associated with A-69. Abolishes inhibition of NFKB2 processing; when associated with A-67.,MUTAGEN:K->R: Abolished ubiquitination by the SCF(FBXL2) complex.,MUTAGEN:K->R: Reduces 'Lys-48'-linked polyubiquitination; when associated with R-106.,MUTAGEN:K->R: Reduces 'Lys-48'-linked polyubiquitination; when associated with R-155.,MUTAGEN:W->A: Decreased interaction with FBXL2.,MUTAGEN:Y->F: Loss of interaction with MAVS.,REGION:Disordered,ZN_FING:RING-type,ZN_FING:TRAF-type,ZN_FING:TRAF-type 1,ZN_FING:TRAF-type 2,
Q4R333	actin like 6A(ACTL6A)	Macaca fascicularis			GO:0000723~telomere maintenance,GO:0001825~blastocyst formation,GO:0003407~neural retina development,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006357~regulation of transcription by RNA polymerase II,GO:0007399~nervous system development,GO:0045893~positive regulation of DNA-templated transcription,GO:0045995~regulation of embryonic development,GO:0051726~regulation of cell cycle,GO:0060382~regulation of DNA strand elongation,GO:1904507~positive regulation of telomere maintenance in response to DNA damage,GO:1905168~positive regulation of double-strand break repair via homologous recombination,	GO:0000786~nucleosome,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016514~SWI/SNF complex,GO:0031011~Ino80 complex,GO:0035267~NuA4 histone acetyltransferase complex,GO:0071564~npBAF complex,	GO:0003682~chromatin binding,	IPR004000:Actin,IPR004001:Actin_CS,IPR043129:ATPase_NBD,	mcf03082:ATP-dependent chromatin remodeling,mcf04714:Thermogenesis,mcf05225:Hepatocellular carcinoma,			SM00268:ACTIN,	KW-0227~DNA damage,KW-0233~DNA recombination,KW-0234~DNA repair,KW-0341~Growth regulation,KW-0524~Neurogenesis,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,				KW-0010~Activator,KW-0156~Chromatin regulator,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
P28039	acyloxyacyl hydrolase(AOAH)	Homo sapiens			GO:0006631~fatty acid metabolic process,GO:0009104~lipopolysaccharide catabolic process,GO:0050728~negative regulation of inflammatory response,	GO:0005576~extracellular region,GO:0031410~cytoplasmic vesicle,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0050528~acyloxyacyl hydrolase activity,	IPR001087:GDSL,IPR008139:SaposinB_dom,IPR011001:Saposin-like,IPR036514:SGNH_hydro_sf,IPR039676:AOAH,IPR048593:AOAH_Saposin_N,				SM00741:SapB,	KW-0443~Lipid metabolism,	KW-0964~Secreted,KW-0968~Cytoplasmic vesicle,		KW-0732~Signal,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0865~Zymogen,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DISULFID:Interchain (between small and large subunit),DOMAIN:Saposin B-type,MUTAGEN:G->M: Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.,MUTAGEN:K->E: No effect on enzyme activity.,MUTAGEN:K->E: No effect on enzyme activity; when associated with E-345.,MUTAGEN:P->M: Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.,MUTAGEN:R->E: No effect on enzyme activity; when associated with E-379.,MUTAGEN:S->A: Loss of enzyme activity.,MUTAGEN:S->L: Nearly abolishes catalytic activity.,MUTAGEN:T->A: Loss of glycosylation. No effect on enzyme activity or localization to cytoplasmic vesicles.,REGION:Disordered,REGION:Important for enzyme activity, localization to cytoplasmic vesicles, and protein stability,REGION:Lipopolysaccharide binding,SITE:Interacts with lipopolysaccharide,
Q5REI7	adenylate kinase 2(AK2)	Pongo abelii			GO:0006172~ADP biosynthetic process,GO:0046033~AMP metabolic process,GO:0046034~ATP metabolic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0097226~sperm mitochondrial sheath,	GO:0004017~adenylate kinase activity,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,	IPR000850:Adenylat/UMP-CMP_kin,IPR006259:Adenyl_kin_sub,IPR007862:Adenylate_kinase_lid-dom,IPR027417:P-loop_NTPase,IPR028587:AK2,IPR033690:Adenylat_kinase_CS,	pon00230:Purine metabolism,pon00730:Thiamine metabolism,pon01100:Metabolic pathways,pon01232:Nucleotide metabolism,pon01240:Biosynthesis of cofactors,					KW-0496~Mitochondrion,			KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	DOMAIN:Adenylate kinase active site lid,REGION:Disordered,REGION:LID,REGION:NMP,REGION:NMPbind,
Q5F3X4	elongation factor Tu GTP binding domain containing 2(EFTUD2)	Gallus gallus		Translation, ribosomal structure and biogenesis,	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005829~cytosol,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0030623~U5 snRNA binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR031950:EFTUD2_N,IPR035647:EFG_III/V,IPR035655:U5-116kDa_C,IPR041095:EFG_II,IPR044121:Snu114_GTP-bd,	gga03040:Spliceosome,			SM00838:EFG_C,SM00889:EFG_IV,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,			KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Acidic residues,DOMAIN:Elongation factor EFG,DOMAIN:Tr-type G,DOMAIN:Translation elongation factor EFG/EF2,DOMAIN:tr-type G,REGION:Disordered,
Q5R6Y1	enolase 1(ENO1)	Pongo abelii			GO:0006096~glycolytic process,GO:0061621~canonical glycolysis,	GO:0000015~phosphopyruvate hydratase complex,GO:0005886~plasma membrane,	GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,	IPR000941:Enolase,IPR020809:Enolase_CS,IPR020810:Enolase_C,IPR020811:Enolase_N,IPR029017:Enolase-like_N,IPR036849:Enolase-like_C_sf,	pon00010:Glycolysis / Gluconeogenesis,pon01100:Metabolic pathways,pon01200:Carbon metabolism,pon01230:Biosynthesis of amino acids,pon03018:RNA degradation,pon04066:HIF-1 signaling pathway,pon04820:Cytoskeleton in muscle cells,		PIRSF001400:Enolase,	SM01192:Enolase_C,SM01193:Enolase_N,	KW-0324~Glycolysis,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,			KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0456~Lyase,	KW-0007~Acetylation,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	ACT_SITE:Proton acceptor,ACT_SITE:Proton donor,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Enolase C-terminal TIM barrel,DOMAIN:Enolase N-terminal,REGION:Required for interaction with PLG,
E7FAW3	neurobeachin-like 2(nbeal2)	Danio rerio			GO:0008104~protein localization,GO:0030220~platelet formation,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,	GO:0019901~protein kinase binding,	IPR000409:BEACH_dom,IPR001680:WD40_rpt,IPR011989:ARM-like,IPR011993:PH-like_dom_sf,IPR013320:ConA-like_dom_sf,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016024:ARM-type_fold,IPR023362:PH-BEACH_dom,IPR031570:NBEA/BDCP_DUF4704,IPR036322:WD40_repeat_dom_sf,IPR036372:BEACH_dom_sf,IPR046851:NBCH_WD40,IPR046852:Neurobeachin_a-sol,IPR050865:BEACH_Domain,				SM00320:WD40,SM01026:Beach,		KW-0256~Endoplasmic reticulum,		KW-0677~Repeat,KW-0853~WD repeat,				COMPBIAS:Polar residues,DOMAIN:BEACH,DOMAIN:BEACH-type PH,REGION:Disordered,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q8CFI7	polymerase (RNA) II (DNA directed) polypeptide B(Polr2b)	Mus musculus			GO:0001059~transcription by RNA polymerase IV,GO:0001060~transcription by RNA polymerase V,GO:0001172~RNA-templated transcription,GO:0006360~transcription by RNA polymerase I,GO:0006366~transcription by RNA polymerase II,GO:0006383~transcription by RNA polymerase III,GO:0006390~mitochondrial transcription,GO:0042793~plastid transcription,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~RNA polymerase II, core complex,	GO:0001054~RNA polymerase I activity,GO:0001055~RNA polymerase II activity,GO:0001056~RNA polymerase III activity,GO:0001057~RNA polymerase IV activity,GO:0001058~RNA polymerase V activity,GO:0001065~mitochondrial single subunit type RNA polymerase activity,GO:0001066~plastid single subunit type RNA polymerase activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0003968~RNA-dependent RNA polymerase activity,GO:0016787~hydrolase activity,GO:0032549~ribonucleoside binding,GO:0046872~metal ion binding,	IPR007120:DNA-dir_RNAP_su2_dom,IPR007121:RNA_pol_bsu_CS,IPR007641:RNA_pol_Rpb2_7,IPR007642:RNA_pol_Rpb2_2,IPR007644:RNA_pol_bsu_protrusion,IPR007645:RNA_pol_Rpb2_3,IPR007646:RNA_pol_Rpb2_4,IPR007647:RNA_pol_Rpb2_5,IPR014724:RNA_pol_RPB2_OB-fold,IPR015712:DNA-dir_RNA_pol_su2,IPR037033:DNA-dir_RNAP_su2_hyb_sf,IPR037034:RNA_pol_Rpb2_2_sf,	mmu03020:RNA polymerase,mmu03420:Nucleotide excision repair,mmu05016:Huntington disease,				KW-0804~Transcription,	KW-0240~DNA-directed RNA polymerase,KW-0539~Nucleus,KW-9994~DNA-directed RNA polymerase,		KW-0863~Zinc-finger,	KW-0460~Magnesium,KW-0479~Metal-binding,KW-0862~Zinc,	KW-0378~Hydrolase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0488~Methylation,KW-0597~Phosphoprotein,	ZN_FING:C4-type,
P57059	salt inducible kinase 1(SIK1)	Homo sapiens			GO:0002028~regulation of sodium ion transport,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0007346~regulation of mitotic cell cycle,GO:0010830~regulation of myotube differentiation,GO:0010868~negative regulation of triglyceride biosynthetic process,GO:0032792~negative regulation of CREB transcription factor activity,GO:0035556~intracellular signal transduction,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043276~anoikis,GO:0045595~regulation of cell differentiation,GO:0045721~negative regulation of gluconeogenesis,GO:0046777~protein autophosphorylation,GO:0048511~rhythmic process,GO:0055007~cardiac muscle cell differentiation,GO:2000210~positive regulation of anoikis,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004676~3-phosphoinositide-dependent protein kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004711~ribosomal protein S6 kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008140~cAMP response element binding protein binding,GO:0019901~protein kinase binding,GO:0035175~histone H3S10 kinase activity,GO:0035402~histone H3T11 kinase activity,GO:0035403~histone H3T6 kinase activity,GO:0035979~histone H2AXS139 kinase activity,GO:0042826~histone deacetylase binding,GO:0044022~histone H3S28 kinase activity,GO:0044023~histone H4S1 kinase activity,GO:0044024~histone H2AS1 kinase activity,GO:0044025~histone H2BS14 kinase activity,GO:0071889~14-3-3 protein binding,GO:0072354~histone H3T3 kinase activity,GO:0072371~histone H2AS121 kinase activity,GO:0072518~Rho-dependent protein serine/threonine kinase activity,GO:0106310~protein serine kinase activity,GO:0140823~histone H2BS36 kinase activity,GO:0140855~histone H3S57 kinase activity,GO:0140857~histone H3T45 kinase activity,GO:1990244~histone H2AT120 kinase activity,	IPR000719:Prot_kinase_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015940:UBA,IPR017090:Ser/Thr_kinase_SIK1/2,IPR017441:Protein_kinase_ATP_BS,IPR034672:SIK,	hsa04922:Glucagon signaling pathway,	616341~Developmental and epileptic encephalopathy 30,	PIRSF037014:Ser/Thr_PK_SNF1-like,	SM00220:S_TKc,	KW-0090~Biological rhythms,KW-0131~Cell cycle,KW-0221~Differentiation,	KW-0539~Nucleus,KW-0963~Cytoplasm,	KW-0043~Tumor suppressor,KW-0225~Disease variant,KW-0887~Epilepsy,		KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,KW-9996~Developmental protein,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:Protein kinase,DOMAIN:UBA,MUTAGEN:K->M: Loss of kinase activity.,MUTAGEN:S->A,D,C,G: Impaired autophosphorylation and kinase activity.,MUTAGEN:S->A: Decreased kinase activity without affecting much autophosphorylation status.,MUTAGEN:S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. Resistant to inhibition by cAMP signaling and, thus, still able to inhibit TORC activity; when associated with A-473.,MUTAGEN:S->E: Strongly reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.,MUTAGEN:S->T: Does not autophosphorylation and kinase activity.,MUTAGEN:T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Reduced inhibition of CRTC3-mediated transcriptional activity.,MUTAGEN:T->A: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. Resistant to inhibition by cAMP signaling and, thus, still able to inhibit TORC activity; when associated with A-575.,MUTAGEN:T->E: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.,REGION:Disordered,REGION:RK-rich region; required for cAMP responsiveness and nuclear localization,
Q8R235	transmembrane protein 203(Tmem203)	Mus musculus			GO:0006874~intracellular calcium ion homeostasis,GO:0007283~spermatogenesis,	GO:0005765~lysosomal membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016020~membrane,	GO:0003674~molecular_function,	IPR019396:TM_Fragile-X-F-assoc,						KW-0256~Endoplasmic reticulum,KW-0458~Lysosome,KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Interaction with STING1,REGION:Required for lysosomal localization of the STING-TMEM203 complex,TRANSMEM:Helical,
P52483	ubiquitin-conjugating enzyme E2E 3(Ube2e3)	Mus musculus			GO:0070534~protein K63-linked ubiquitination,GO:0070936~protein K48-linked ubiquitination,GO:0070979~protein K11-linked ubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,	mmu04120:Ubiquitin mediated proteolysis,			SM00212:UBCc,	KW-0341~Growth regulation,KW-0833~Ubl conjugation pathway,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:UBC core,MUTAGEN:C->S,A: Loss of enzymatic activity, interaction with IPO11, nuclear import, and effect on cell growth.,REGION:Disordered,
